BBOT

Quanta Therapeutics

This biopharmaceutical company develops oral small-molecule medicines for patients with RAS-driven cancers by targeting protein-protein interactions to inhibit oncogenic signaling.

Kinnate Biopharma

The company develops small molecule kinase inhibitors for patients with difficult-to-treat cancers featuring specific genetic alterations.

Biopharmaceutical company

This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.

ARase Therapeutics

This company develops small molecule drugs targeting ADP-ribose hydrolases for patients with various forms of cancer.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Kronos Bio

This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

BlossomHill Therapeutics

This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.